Immunological Directives for Biotherapy Improvement in the Treatment of Colorectal Cancer-Reference-Cited by-同舟云学术

Immunological Directives for Biotherapy Improvement in the Treatment of Colorectal Cancer

Published:1996-04 Issue:2 Volume:11 Page:113-118
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Pellegrini Patrizia,Berghella Anna Maria,Del Beato Tiziana,Adorno Domenico,Casciani Carlo Umberto

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.1996.11.113

Reference25 articles.

1. the influence of autologous lymphokine-activated killer cell infusions on the toxicity and antitumor effect of repetitive cycles of interleukin-2

2. Immunotherapy with Sensitized Lymphocytes

3. Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Gender-specific Cytokine Pathways as Drug Targets and Gender- specific Biomarkers in Personalized Cancer Therapy;Current Drug Targets;2017-02-06

2. Colon Cancer and Gene Alterations: Their Immunological Implications and Suggestions for Prognostic Indices and Improvements in Biotherapy;Cancer Biotherapy and Radiopharmaceuticals;2006-10

3. Are Immunological Mechanisms Involved in Colon Cancer and Are They Possible Markers for Biotherapy Improvement?;Cancer Biotherapy and Radiopharmaceuticals;2006-10

4. The Study of a Patient's Immune System May Prove to be a Useful Noninvasive Tool for Stage Classification in Colon Cancer;Cancer Biotherapy and Radiopharmaceuticals;2006-10

5. Passage from Normal Mucosa to Adenoma and Colon Cancer: Alteration of Normal sCD30 Mechanisms Regulating TH1/TH2 Cell Functions;Cancer Biotherapy and Radiopharmaceuticals;2003-08